Delivery Order SPE2DE24D0013-SPE2D626F35VB
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a firm fixed-price delivery order valued at $36,720 on January 23, 2026, with completion expected by January 30, 2026. This delivery order, designated XPRS4PLEX-10, represents a child contract under Cepheid's single-award Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at $6.7 million through December 28, 2029. The contract does not utilize a set-aside...
- The Defense Logistics Agency Medical Supply Chain awarded a $5,440 firm fixed-price delivery order to Cepheid Inc. on January 13, 2026, with an ultimate completion date of January 21, 2026. This delivery order, identified as XPRS4PLEX-10, is a child contract issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs VISN 6, valued at $32.8 million and extending through September 30, 2030. The contract involves the supply of molecular diagnostic testing...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $34,000 firm fixed-price delivery order (Contract 4570371726, XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 29, 2025, with an ultimate completion date of January 6, 2026. This delivery order, which carries no set-aside designation, is issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at...
- The Department of Defense's Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $20,994.88 to Cepheid Inc. on January 23, 2026, for diagnostic reagents and test kits under a firm fixed-price arrangement with no set-aside designation. This delivery order, which is expected to be completed by January 30, 2026, represents a child contract issued against Cepheid's larger Indefinite Delivery Contract (IDC) with the Veterans Integrated Service Network (VISN) 6, valued at...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. on January 14, 2026, under contract number 4570533423 (XPRS4PLEX-10). This delivery order is a child contract issued under one of Cepheid's existing Indefinite Delivery Contracts with the Department of Veterans Affairs. The order calls for the delivery of XPRS4PLEX-10 cartridges and related molecular diagnostic testing reagents and assays designed for use with Cepheid's...
- The Defense Logistics Agency Medical Supply Chain awarded a $8,640 firm fixed-price delivery order to Cepheid Inc. on January 21, 2026, for diagnostic reagents and test kits. This delivery order, valued at the ceiling amount, represents a child contract under Cepheid's larger Indefinite Delivery Contract (IDC) vehicle with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, which is valued at $6.74 million through December 28, 2029. The delivery order is for...
- The Defense Logistics Agency Medical Supply Chain awarded a $9,520 firm fixed-price delivery order to Cepheid Inc. on January 27, 2026, for diagnostic supplies and reagents. This delivery order, designated XPRS4PLEX-10, is scheduled for completion by February 3, 2026, and represents a child contract under Cepheid's larger indefinite delivery vehicle with the Department of Veterans Affairs. The contract involves no set-aside designation and will be performed at Cepheid's headquarters in...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $20,350 by the Defense Logistics Agency Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 20, 2026. This delivery order, designated as XPRS4PLEX-10, represents a child contract under Cepheid's larger Indefinite Delivery Contract vehicle with the Veterans Health Administration VISN 6, valued at $32.8 million and extending through September 30, 2030. The...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $7,480 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 14, 2026. This delivery order, valued at the ceiling amount, is issued under Cepheid's larger Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network 17, which is valued at $6.7...
- The Defense Logistics Agency Medical Supply Chain has awarded a delivery order valued at $14,552 to Cepheid Inc. under an Indefinite Delivery Contract with the Department of Veterans Affairs VISN 17. This firm fixed-price delivery order, issued on January 21, 2026, with an ultimate completion date of January 28, 2026, pertains to XPRS4PLEX-10 cartridges—molecular diagnostic reagents designed for Cepheid's GeneXpert diagnostic platform. The order represents a child contract without set-aside...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F35VBDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a $5,184 firm fixed-price delivery order on January 30, 2026, for diagnostic testing supplies and reagents. This delivery order, valued at the ceiling amount, is a child contract issued under Cepheid's larger Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network 6 (VISN 6), which carries a total value of approximately $32.8 million through September 30, 2030. The contract utilizes no set-aside designation and is scheduled for ultimate completion on February 6, 2026, with performance occurring at Cepheid's Sunnyvale, California headquarters. The specific deliverable under this award is the XPRS4PLEX-10 cartridge, a molecular diagnostic reagent designed for the GeneXpert diagnostic platform that enables detection of multiple respiratory pathogens. Cepheid has established itself as a primary federal supplier of advanced molecular diagnostic systems and reagents across the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company's GeneXpert diagnostic platform and associated testing capabilities provide rapid molecular detection for conditions including COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other infectious diseases. This delivery order represents routine procurement activity within Cepheid's established federal contracting relationships, specifically supporting VA healthcare laboratory operations and infectious disease testing requirements across the VISN 6 network of medical centers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 1/29/26 |